nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—XDH—Oxidative Stress—SOD1—Parkinson's disease	0.0231	0.0231	CbGpPWpGaD
Pyrazinamide—XDH—Oxidative Stress—MAOA—Parkinson's disease	0.0225	0.0225	CbGpPWpGaD
Pyrazinamide—XDH—Oxidative Stress—HMOX1—Parkinson's disease	0.0222	0.0222	CbGpPWpGaD
Pyrazinamide—AOX1—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.0209	0.0209	CbGpPWpGaD
Pyrazinamide—XDH—Oxidative Stress—SOD2—Parkinson's disease	0.0208	0.0208	CbGpPWpGaD
Pyrazinamide—XDH—Oxidative Stress—GPX1—Parkinson's disease	0.0198	0.0198	CbGpPWpGaD
Pyrazinamide—XDH—Purine metabolism—GPX1—Parkinson's disease	0.0184	0.0184	CbGpPWpGaD
Pyrazinamide—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.014	0.014	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.014	0.014	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—INSR—Parkinson's disease	0.0139	0.0139	CbGpPWpGaD
Pyrazinamide—CYP1A2—Methylation—COMT—Parkinson's disease	0.0115	0.0115	CbGpPWpGaD
Pyrazinamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.0108	0.0108	CbGpPWpGaD
Pyrazinamide—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.0104	0.0104	CbGpPWpGaD
Pyrazinamide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00997	0.00997	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.00976	0.00976	CbGpPWpGaD
Pyrazinamide—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.0095	0.0095	CbGpPWpGaD
Pyrazinamide—XDH—Nucleotide metabolism—GPX1—Parkinson's disease	0.00923	0.00923	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.00879	0.00879	CbGpPWpGaD
Pyrazinamide—CYP1A2—Xenobiotics—CYP2D6—Parkinson's disease	0.00869	0.00869	CbGpPWpGaD
Pyrazinamide—CYP1A2—Estrogen metabolism—NQO1—Parkinson's disease	0.00855	0.00855	CbGpPWpGaD
Pyrazinamide—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Parkinson's disease	0.0084	0.0084	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00838	0.00838	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00836	0.00836	CbGpPWpGaD
Pyrazinamide—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00802	0.00802	CbGpPWpGaD
Pyrazinamide—CYP1A2—Xenobiotics—CYP2E1—Parkinson's disease	0.00795	0.00795	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00774	0.00774	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00764	0.00764	CbGpPWpGaD
Pyrazinamide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00733	0.00733	CbGpPWpGaD
Pyrazinamide—CYP1A2—Estrogen metabolism—COMT—Parkinson's disease	0.00717	0.00717	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tryptophan metabolism—DDC—Parkinson's disease	0.00713	0.00713	CbGpPWpGaD
Pyrazinamide—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.00671	0.00671	CbGpPWpGaD
Pyrazinamide—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.0066	0.0066	CbGpPWpGaD
Pyrazinamide—CYP1A2—Estrogen metabolism—GSTM1—Parkinson's disease	0.00655	0.00655	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00646	0.00646	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00645	0.00645	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—INS—Parkinson's disease	0.00615	0.00615	CbGpPWpGaD
Pyrazinamide—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00613	0.00613	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.00601	0.00601	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.0059	0.0059	CbGpPWpGaD
Pyrazinamide—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00553	0.00553	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00551	0.00551	CbGpPWpGaD
Pyrazinamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00545	0.00545	CbGpPWpGaD
Pyrazinamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.0052	0.0052	CbGpPWpGaD
Pyrazinamide—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00506	0.00506	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—VPS35—Parkinson's disease	0.00502	0.00502	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00486	0.00486	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MCCC1—Parkinson's disease	0.00466	0.00466	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00463	0.00463	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00459	0.00459	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00453	0.00453	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—OMD—Parkinson's disease	0.00438	0.00438	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TALDO1—Parkinson's disease	0.00438	0.00438	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00408	0.00408	CbGpPWpGaD
Pyrazinamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00406	0.00406	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.00404	0.00404	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00404	0.00404	CbGpPWpGaD
Pyrazinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00401	0.00401	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.00401	0.00401	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00394	0.00394	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ND3—Parkinson's disease	0.00391	0.00391	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MCCC1—Parkinson's disease	0.00391	0.00391	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00368	0.00368	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TALDO1—Parkinson's disease	0.00367	0.00367	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—OMD—Parkinson's disease	0.00367	0.00367	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ND3—Parkinson's disease	0.00363	0.00363	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MCCC1—Parkinson's disease	0.00363	0.00363	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00361	0.00361	CbGpPWpGaD
Pyrazinamide—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00356	0.00356	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TAF1—Parkinson's disease	0.00353	0.00353	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FBP1—Parkinson's disease	0.00353	0.00353	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NDUFB11—Parkinson's disease	0.00348	0.00348	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TALDO1—Parkinson's disease	0.00341	0.00341	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—OMD—Parkinson's disease	0.00341	0.00341	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—TNF—Parkinson's disease	0.00333	0.00333	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GCH1—Parkinson's disease	0.00332	0.00332	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.0033	0.0033	CbGpPWpGaD
Pyrazinamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00329	0.00329	CbGpPWpGaD
Pyrazinamide—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00326	0.00326	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NDUFB11—Parkinson's disease	0.00324	0.00324	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00315	0.00315	CbGpPWpGaD
Pyrazinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00313	0.00313	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GCH1—Parkinson's disease	0.00309	0.00309	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00304	0.00304	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GBA—Parkinson's disease	0.00296	0.00296	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—FBP1—Parkinson's disease	0.00296	0.00296	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—DBH—Parkinson's disease	0.00296	0.00296	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00293	0.00293	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPL6—Parkinson's disease	0.00283	0.00283	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SNCA—Parkinson's disease	0.00283	0.00283	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00279	0.00279	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00277	0.00277	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—DBH—Parkinson's disease	0.00275	0.00275	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GBA—Parkinson's disease	0.00275	0.00275	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—FBP1—Parkinson's disease	0.00275	0.00275	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00275	0.00275	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—IL6—Parkinson's disease	0.00269	0.00269	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00268	0.00268	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00255	0.00255	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00251	0.00251	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.00235	0.00235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00231	0.00231	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00226	0.00226	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.0022	0.0022	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—DDC—Parkinson's disease	0.00217	0.00217	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPL14—Parkinson's disease	0.00214	0.00214	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPL23A—Parkinson's disease	0.00214	0.00214	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.00209	0.00209	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00206	0.00206	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTA4—Parkinson's disease	0.00205	0.00205	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—DDC—Parkinson's disease	0.00202	0.00202	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.00201	0.00201	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.002	0.002	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGF20—Parkinson's disease	0.002	0.002	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPS8—Parkinson's disease	0.002	0.002	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTA4—Parkinson's disease	0.00191	0.00191	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PLA2G6—Parkinson's disease	0.00185	0.00185	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.00184	0.00184	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MAOB—Parkinson's disease	0.00183	0.00183	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00181	0.00181	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00179	0.00179	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PLA2G6—Parkinson's disease	0.00172	0.00172	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MAOB—Parkinson's disease	0.0017	0.0017	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.0017	0.0017	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.00162	0.00162	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00161	0.00161	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.00155	0.00155	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ADRBK1—Parkinson's disease	0.00147	0.00147	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HSPA1A—Parkinson's disease	0.00146	0.00146	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.00142	0.00142	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.0014	0.0014	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP2D6—Parkinson's disease	0.00136	0.00136	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CTGF—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.0013	0.0013	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP2D6—Parkinson's disease	0.00126	0.00126	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP2E1—Parkinson's disease	0.00124	0.00124	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CTGF—Parkinson's disease	0.00124	0.00124	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NQO1—Parkinson's disease	0.00123	0.00123	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TH—Parkinson's disease	0.00121	0.00121	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.0012	0.0012	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00118	0.00118	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.00118	0.00118	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.00118	0.00118	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00118	0.00118	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYCS—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP2E1—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NQO1—Parkinson's disease	0.00114	0.00114	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TH—Parkinson's disease	0.00113	0.00113	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYCS—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00106	0.00106	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—COMT—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTP1—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MAOA—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HMOX1—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTHFR—Parkinson's disease	0.000994	0.000994	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ABCB1—Parkinson's disease	0.00097	0.00097	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—COMT—Parkinson's disease	0.000958	0.000958	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTP1—Parkinson's disease	0.000953	0.000953	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MAOA—Parkinson's disease	0.000951	0.000951	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTM1—Parkinson's disease	0.000942	0.000942	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HMOX1—Parkinson's disease	0.00094	0.00094	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOE—Parkinson's disease	0.000925	0.000925	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000909	0.000909	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000905	0.000905	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000902	0.000902	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GPX1—Parkinson's disease	0.000902	0.000902	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ABCB1—Parkinson's disease	0.000902	0.000902	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000896	0.000896	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000892	0.000892	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTM1—Parkinson's disease	0.000876	0.000876	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GPX1—Parkinson's disease	0.000839	0.000839	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MTHFR—Parkinson's disease	0.000833	0.000833	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000831	0.000831	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00082	0.00082	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000811	0.000811	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—INS—Parkinson's disease	0.000791	0.000791	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOE—Parkinson's disease	0.000775	0.000775	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MTHFR—Parkinson's disease	0.000774	0.000774	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000764	0.000764	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000764	0.000764	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOE—Parkinson's disease	0.000721	0.000721	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—OMD—Parkinson's disease	0.000718	0.000718	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.000718	0.000718	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000681	0.000681	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—INS—Parkinson's disease	0.000662	0.000662	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.000649	0.000649	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—INS—Parkinson's disease	0.000616	0.000616	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000589	0.000589	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000589	0.000589	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000586	0.000586	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000579	0.000579	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000579	0.000579	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000579	0.000579	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000554	0.000554	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000554	0.000554	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000525	0.000525	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000501	0.000501	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000447	0.000447	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000447	0.000447	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000447	0.000447	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—DDC—Parkinson's disease	0.000425	0.000425	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.000401	0.000401	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000396	0.000396	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.000361	0.000361	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000358	0.000358	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—Parkinson's disease	0.000345	0.000345	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00034	0.00034	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000328	0.000328	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.00031	0.00031	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000279	0.000279	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000276	0.000276	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	0.000266	0.000266	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CTGF—Parkinson's disease	0.000261	0.000261	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	0.000243	0.000243	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NQO1—Parkinson's disease	0.00024	0.00024	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TH—Parkinson's disease	0.000237	0.000237	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYCS—Parkinson's disease	0.000227	0.000227	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000205	0.000205	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—COMT—Parkinson's disease	0.000201	0.000201	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000201	0.000201	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTP1—Parkinson's disease	0.0002	0.0002	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MAOA—Parkinson's disease	0.0002	0.0002	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMOX1—Parkinson's disease	0.000198	0.000198	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCB1—Parkinson's disease	0.00019	0.00019	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.000188	0.000188	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000185	0.000185	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—Parkinson's disease	0.000184	0.000184	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TH—Parkinson's disease	0.000183	0.000183	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX1—Parkinson's disease	0.000176	0.000176	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYCS—Parkinson's disease	0.000176	0.000176	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTHFR—Parkinson's disease	0.000163	0.000163	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—COMT—Parkinson's disease	0.000155	0.000155	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	0.000155	0.000155	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MAOA—Parkinson's disease	0.000154	0.000154	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	0.000153	0.000153	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOE—Parkinson's disease	0.000152	0.000152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	0.000146	0.000146	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	0.000142	0.000142	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX1—Parkinson's disease	0.000136	0.000136	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—INS—Parkinson's disease	0.000129	0.000129	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	0.000126	0.000126	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOE—Parkinson's disease	0.000117	0.000117	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—INS—Parkinson's disease	9.99e-05	9.99e-05	CbGpPWpGaD
